Share
1,417 Posts.
lightbulb Created with Sketch. 253
clock Created with Sketch. 31/01/22
21:58
Share
Originally posted by Gongboy:
↑
I think Mike's view was that you had to spend money to make money, and that is fine if you are growing revenue quickly. I did once look at how much each sales person sold against their salary (cant recall the figure) but it was quite astounding how little they each sold. Their business model relied of rapid uptake in the US (this is already the most expensive medicine in the world, so you would think that another $350 for DyeVert would have been easy). But it wasn't - and still isn't. You would think insurers would be pushing it if it reduced hospital costs - but they don't seem to be, and you would think hospitals and doctors would be sued for not using the latest available tech to reduce complications.
Expand
It all comes back to their failure in the original study to show that it affected mortality rates. That is what really killed it, after that they were flogging a dead horse. I had invested previously until I worked out what was really going on.
